Application
Western blot analysis of extract from A431 ce lls, untreated or treated with EGF (200ng/ml, 5min), using Bcr Antibody (Y177) (#AE1006a, Lane 1 and 2) and Phospho-Bcr-Y177 Antibody (#AE1006b, Lane 3 and 4).Application
Immunohistochemical analysis of paraffin-embedded human tonsil tumor tissue, using Phospho-Bcr-Y177 Antibody (#AE1006b).| Product Name | Phospho-Bcr-Y177 Antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Modification | p-Y177 |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:500~1:1000 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | BCR1, D22S11 |
|---|---|
| Alternative Names | Renal carcinoma antigen NY-REN-26 Breakpoint cluster region protein |
| Molecular Weight(MW) | 142819 Da |
| Function | GTPase-activating protein for RAC1 and CDC42. Promotes the exchange of RAC or CDC42-bound GDP by GTP, thereby activating them. Displays serine/threonine kinase activity |
| Tissue Specificity | The antibody was affinity-purified from rabbit antiserum using epitope-specific phosphopeptide column, and the antibody against non-phosphopeptide was removed using non-phosphopeptide column corresponding to the phosphorylation site. |
| Entrez Gene | 613 |
|---|
Application
Western blot analysis of extract from A431 ce lls, untreated or treated with EGF (200ng/ml, 5min), using Bcr Antibody (Y177) (#AE1006a, Lane 1 and 2) and Phospho-Bcr-Y177 Antibody (#AE1006b, Lane 3 and 4).
Application
Immunohistochemical analysis of paraffin-embedded human tonsil tumor tissue, using Phospho-Bcr-Y177 Antibody (#AE1006b).| Application Notes | WB:1:500~1:1000 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | affinity Purified IgG, in PBS, 0.02% sodium azide and 50% glycerol. |
